SOPHiA GENETICS and AstraZeneca Expand AI Collaboration for Breast Cancer Treatment
SOPHiA GENETICS has announced an expansion of its collaboration with AstraZeneca to enhance breast cancer treatment outcomes using artificial intelligence, announced in a press release. This multi-year partnership will utilize SOPHiA GENETICS's multimodal AI Factories to generate evidence on the efficacy and real-world impact of therapies for certain types of breast cancer.
The collaboration aims to develop a bespoke AI-powered predictive model to optimize treatment outcomes for breast cancer patients. SOPHiA GENETICS's AI Factories will analyze multimodal healthcare data, including genomics, imaging, and clinical data, to provide insights that can improve patient prognosis and treatment response.
AstraZeneca will use these insights to enhance clinical decision-making and address critical knowledge gaps in breast cancer treatment. The partnership will also focus on generating real-world evidence in Europe and North America to uncover key drivers of treatment efficacy.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
AbbVie Partners With Valkai on AI Tools for Clinical Development
The Saffron Solution Brings AI Workflow Tools to AAO 2026
SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool
Suvoda Expands Sofia to All New RTSM and eCOA Trials
Teragonia Launches Astra Labs for Enterprise AI Workflows
Daily AI Brief: the AI news that matters, in your inbox.